Under the C-diff section on Immuron’s website it says- “Results for Immuron’s animal recurrence studies will be available this January. Positive results in the study would conclude that IMM-529 would be beneficial in treatments for all three phases of the disease, prevention, initial treatment, and recurrence, with recurrence being the largest unmet need
“
Anyone heard anything about the results because it is already February?
- Forums
- ASX - By Stock
- C-diff results.
Under the C-diff section on Immuron’s website it says- “Results...
-
- There are more pages in this discussion • 16 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add IMC (ASX) to my watchlist
|
|||||
Last
9.8¢ |
Change
-0.002(2.00%) |
Mkt cap ! $22.34M |
Open | High | Low | Value | Volume |
9.9¢ | 9.9¢ | 9.8¢ | $14.54K | 148.1K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 10416 | 9.6¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
9.8¢ | 29295 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 10416 | 0.096 |
2 | 81877 | 0.095 |
2 | 84702 | 0.092 |
4 | 221455 | 0.090 |
1 | 90000 | 0.089 |
Price($) | Vol. | No. |
---|---|---|
0.098 | 29295 | 1 |
0.100 | 750 | 1 |
0.110 | 208068 | 1 |
0.115 | 119000 | 2 |
0.120 | 253253 | 5 |
Last trade - 15.53pm 06/08/2024 (20 minute delay) ? |
Featured News
IMC (ASX) Chart |